Dianthus Therapeutics price target set at $135 by JP Morgan
JP Morgan initiated coverage of Dianthus Therapeutics with an Overweight rating and a $135.00/share price target.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.